TRPV2 interaction with small molecules and lipids revealed by cryo-EM

Published: Aug. 10, 2020, 1:02 p.m.

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.08.10.242008v1?rss=1 Authors: Protopopova, A. D., Pumroy, R. A., de la Roche, J., Haug, F. M., Sousa, B. B., Gallo, P. N., Bernardes, G. J. L., Leffler, A., Moiseenkova-Bell, V. Abstract: Transient receptor potential vanilloid 2 (TRPV2) plays a critical role in a variety of physiological and pathophysiological processes, putting TRPV2 on the list of important drug targets. Yet, specific TRPV2 agonists and antagonists are currently unavailable. Their development requires a precise knowledge of how the currently known non-specific small molecules interact with TRPV2 at the molecular level. Here we present TRPV2 structures in ligand-bound states resolved by cryo-electron microscopy in the presence of 2-aminoethoxydiphenyl borate (2-ABP), 2-APB with doxorubicin (DOXO), and ruthenium red (RR). We identified a novel 2-APB drug binding site between the S5 helix and S4-S5 linker on two adjacent TRPV2 monomers and determined the mechanism of TRPV2 pore block by RR. We also showed that a large organic molecule like DOXO can enter the TRPV2 pore in the presence of 2-APB. Additionally, we discovered a structural lipid bound in a unique position in the vanilloid pocket, which is absent in the 2-APB-bound state of the channel, allowing us to propose a model for TRPV2 channel gating. Together, this work provides a further understanding of TRPV2 function and a structural framework for the development of TRPV2-specific modulators. Copy rights belong to original authors. Visit the link for more info